CDRH Software Forensics Lab: Applying Rocket Science To Device Analysis
This article was originally published in The Gray Sheet
Executive Summary
CDRH's recently upgraded "software forensics lab" marks a substantial financial and time investment by the center to get at the root cause of the most troubling postmarket device software failures, but the agency hopes manufacturers will pick up the tab in the future to prevent dangerous anomalies before their products hit the market
You may also be interested in...
Another Class I Correction Needed On Baxter Infusion Pumps
A recall initiated last month by Baxter removing 4,500 upgraded versions of its triple-channel Colleague infusion pumps from use was designated Class I by FDA July 18
Software Glitch Prompts St. Jude Recall; Firm Follows HRS Notification Recs
St. Jude Medical is awaiting FDA approval of a software fix for certain tabletop programmers used to program pacemakers
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.